New study aims to sharpen COVID-19 testing and uncover immunity secrets
NCT ID NCT04404062
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing different methods to detect COVID-19 infections and measure immunity. Researchers will use PCR tests to find active infections and antibody tests to see who has been infected before. Up to 2500 volunteers, including staff and their families, will participate. The goal is to improve testing accuracy and understand how long immunity lasts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help improve COVID-19 testing methods and provide valuable data on infection rates and immunity duration.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly benefit participants and results may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge
RECRUITINGLondon, London, SE1 1YR, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?